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New Incoherent Autofluorescence/Fluorescence System for
Early Detection of Lung Cancer
MARTIN LEONHARD*
KARL STORZ GmbH & Co., Marketing New Technologies, Mittelstr. 8, D-78532 Tuttlingen, Germany
A new autofluorescence (AF) system for bronchoscopy that operates as compact as a
conventional white light bronchoscopy system is described. The system is also capable ofwhite
light illumination and excitation of aminolevulinic acid (ALA) induced fluorescence.
Changing between white light and (auto-) fluorescence mode is easy and always possible.
Broad band excitation with blue light (AF: 380-460nm; ALA 380-440nm) delivers high
intensity illumination at the distal end of the bronchoscope (AF typically 50mW). A special
optical observation technique makes the AF directly visible to the eye instead of indirect
techniques used in other AF systems. A compact (160 g) and sensitive (typically 0.2 lux)
camera can be used for documentation.
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INTRODUCTION
Perception depends upon the detection technique.
What we see is the result of the brilliant possibilities
of the human eye and the human brain. Vision
enables us to orient and survive in our natural
surroundings. However, only a fraction ofall optical
information is processed in the natural visual chain.
Going beyond normal vision is not necessary for
living but can reveal a lot more information about
the object being observed. Cleverly capturing this
additional information opens the door to new
analytical and diagnostic techniques. One of these
new techniques is to reveal information hidden
inside tissue to discriminate between suspect tumor
tissue and normal tissue.
Basics of Fluorescence Imaging
Common visual pictures correlate the remission
spectrum ofan object with their physical properties:
e.g. color, shape, texture, orientation and motion.
The natural objective is to recognize known struc-
tures. Incident light L(A,x) as a function of
wavelength A and space x, which usually is, "white"
sunlight, illuminates the scenery and the objects
modulate the incident light due to different absorp-
tion and scattering characteristics A(A,x). The
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remitted scattered light IA,S(,x) has the same
wavelength Ar as the incident light Ai.
IA,S(A, x) A(A, x). L(A, x) Ar =/i ,.
For example, blood absorbs light in the blue and
green part and remits the remaining spectrum; the
color of blood is described .as red. This type of
modulation is the dominant process which gives us
orientation in our natural surrounding and in day-
to-day life.
Fluorescence in contrast is an additional effect
that contributes to remission and changes the
wavelength of incident light. Fluorescence F(AF1;
Ai; x) correlates the wavelength of the incident light
/i and the fluorescence light AF1 and therefore
provides additional information. Generally speak-
ing the fluorescent light IF is red shifted.
Iw(Av, x) fF(Av;; x) L(A; x) cl AF1 >
Thus the overall intensity I(A, x) becomes
I(A, x) IA,S(A, x)+ Ivl(Avl, x)
and is generally dominated by absorption and
scattering effects, because fluorescence is weak.
By employing a simple trick we can make
fluorescence visible, i.e. we have to eliminate the
dominating scattering contribution to realize the
fluorescence. This is possible due to the spectral
separation of incident and fluorescent light. By
blocking the wavelength of the incident light in the
observation pathway we eliminate disturbing scat-
tering light and reveal the fluorescence.
Fluorescence originates in chromophores which
can be intrinsic (autofluorescence, AF) or added to
the tumor tissue (xenofluorescence).
Biophysical Effects of Autofluorescence
To evoke AF in the visible range, special molecules
or chromophores are required. Various proteins are
known to display fluorescence when excited in the
near UV or with blue light. These different
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FIGURE Normalized fluorescence spectra of various
tissue chromophores in aqueous solution excited at 308nm
(from left to right: Collagen I, Collagen II, NADH, FADH2).
chromophores are embedded in complex matrices
and provide different micro environments to the
chromophores. Excitation and fluorescence spectra
of the dyes involved are typical broad band spectra.
This effect can be used in the clinical application of
tissue intrinsic (auto-) fluorescence.
Figure displays several molecules which are
expected to play an active role in AF when excited
with a XeC1-Laser at 308 nm [1]. This representation
is chosen for a more complete display ofthe spectra.
Excitation with the KARL STORZ D (Diagnosis)-
Light AF cuts off the short-wavelength part of the
spectra.
The penetration depth of light is wavelength
dependant and increases with wavelength in the
visible range. Blue light penetration depth is limited
to a fraction of a millimeter but is significantly
deeper than UV light penetration depth. Therefore
only the very top layers of tissue can be involved in
optical effects. Fluorescence is suspected to origi-
nate in the submucosal layer.
The modulation responsible for contrasting early
stage tumors is not revealed in detail. One effect is
modified metabolic activity in tumor cells which
effects also fluorescence characteristics. Another
effect is tissue optical based and comes from the
epithelium which absorbs light depending on
the thickness of the layer (Fig. 2) according to
Lambert-Beer’s law. Malignant alterations display
thickened epithelium and therefore appear darker
under AF detection, Additionally, only a smallerKARL STORZ AUTOFLUORESCENCE SYSTEM 73
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FIGURE 2 Tissue optical effect revealing early tumor
stages, e.g. carcinoma in situ (CIS). Excitation at 380-460 nm;
detection at 470-800nm (schematical drawing).
amount ofsubmucosal tissue can be illuminated due
to limited penetration depth.
Biophysical Effects of ALA-induced Fluorescence
Inhalation of the endogeneous substance 5-amino-
levulinic acid (ALA) leads to a tumor sensitive
fluorescence marking. Theheme metabolicpathway
is made use of and transforms ALA into proto-
porhyrin IX (PPIX) which is accumulated in tumor
cells. PPIX shows an absorption maximum at
410nm and fluorescence with broad peaks at 635
and 705 nm. Details are available in this volume
(Huber et al.) and elsewhere [2].
The method of ALA-induced detection of early
tumor stages is successfully applied with D-Light
excitation for detection ofsuperficial bladder cancer
[3], malignant glioma [4] and in various other fields.
MATERIALS AND METHODS
History The incoherent light system used to
induce fluorescence is the new KARL STORZ
D-Light AF system (KARL STORZ, Tuttlingen,
Germany) which is based on a technology devel-
oped for early detection of superficial bladder
cancer [3]. This incoherent diagnostic approach
for ALA-induced fluorescence was found to be
clinically more convenient than a krypton-ion laser
which originally was used for illumination [5].
Rapid technological innovation has created a
powerful bronchoscopy system capable of (auto-)
fluorescence detection. No contrast agent is re-
quired with the autofluorescence technology.
D-Light AF System
The D-Light AF system is handy, weighs less than
10 kg and is capable of three different illumination
modes: (1). Conventional white light mode; (2) AF
mode; (3) ALA-induced fluorescence mode which is
described elsewhere [2]. The system is based on a
300-W Xenon lamp with special optics to focus high
intensities of light into a liquid light guide, which is
optimized for blue light transmission. The modes
can easily be switched any time by a footswitch. In
theAF mode output wavelength is between 380 and
460 nm; in theALA mode between 380 and 440 nm.
Blue light output power for AF at the distal end of
a KARL STORZ broncho-fiberscope is typically
50mW.
Observation
Both rigid telescopes and flexible fiberscopes are
compatible with the KARL STORZ D-Light AF
system. Critical to this method of tumor detection
is the use of the correct observation technique as
mentioned above which is realized in these special
endoscopes. The specially designed endoscopes
contain a filter wheel with three different positions
for white light mode (a), for AF mode (b) and
optionally for ALA-induced fluorescence mode (c).
Position (a) does not contain any filter to allow
standard white light bronchoscopy, whereas posi-
tions (b) and (c) contain observation filters that
block the incident light properly for AF or ALA
mode, respectively. For optimal contrast, specific-
ity, illumination and plasticity a small amount of
the blue excitation light bypasses the detection
filters. With this trick, observation ofbiopsy forceps
or other instruments is ensured even in (auto-)
fluorescence mode.
The complete procedure can be performed
entirely with D-Light AF and the special broncho-
scope, and allows detection with the naked eye
which is known for its high dynamic range. The
technique used is direct imaging instead of indirect
as used in other approaches [6].
The rigid telescopes used are Hopkins bron-
choscopic telescopes with 5.5mm diameter and74 M. LEONHARD
different directions of view (0 and 30). They are
optimized for fluorescence observation as described
above. The 0 telescope provides extremely high
luminous intensity so that white light conditions
can almost be matched in the AF mode to allow
perfect imaging and observation.
The fiberscopes were remodeled, improved and
adapted for (auto-) fluorescence, with both a 5.0mm
(11001 BI) and 6.4mm version (11004 BI) available.
The distal tip has a upward range of 180 movement
and a downward range of 100/80, respectively.
Instrument channels are 2.3/2.8 mm, respectively.
Optical quality is brilliant in both (auto-) fluores-
cence and white light mode.
Documentation
To allow proper documentation special endo-
cameras are available (Telecam SL PDD, Tricam
SL PDD, both KARL STORZ, Tuttlingen,
Germany). These CCD-cameras have a optimized
optical system and allow additional on-chip inte-
gration for the fluorescence modes. With a typical
integration time of 1/15s the Telecam SL PDD
achieves sensitivity better than 0.2 lux. Luminous
sensitivity can be increased by one order of mag-
nitude. The endocamera weighs about 160 g and
therefore has no need for any holding device. The
camera can nicely communicate with the D-Light
AF system to synchronize illumination and detec-
tion modes. For blue light illumination (both AF
and ALA mode) the camera is switched to the blue
light mode from the white light mode which is used
as for conventional endocameras. The blue light
mode allows the extended on-chip-integration as
described above and has a specially adapted built-in
color balancing function for fluorescence mode to
match with the colors that are visually perceived.
The complete system is compact and provides
flexibility by allowing examination ofa fluorescence
finding with the white light as often as necessary.
Additional image storage devices can be easily
configured and added.
Clinical experience is reported in this issue and
elsewhere [2,7-9]. The system is compact (Fig. 3),
FIGURE 3 Karl Storz fluorescence detection system
D-Light AF with fiberbronchoscope 11004 BI and Telecam
SL PDD.
easy to handle, economic and gives brilliant images
for all illumination modes. The KARL STORZ AF
system is CE-marked and commercially available
for the European market and selected countries.
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